Sponsors (2)
The bill tightens federal oversight and coordination to reduce biosafety and biosecurity risks—improving detection, standards, and incident response—while imposing new recordkeeping, disclosure, and compliance costs that raise privacy, operational, and budgetary concerns for researchers, institutions, and taxpayers.
Researchers, public-health officials, and state/local/Tribal governments gain stronger traceability and oversight (electronic logbooks, identity verification, targeted audits, and periodic strategic evaluations) so outbreaks, lab accidents, or misuse of dangerous agents can be detected and responded to more quickly.
Communities near high-containment facilities and local hospitals benefit from nationwide standards for lab design and operation and from improved situational awareness (feasibility study for a centralized lab database), which can reduce biosafety and biosecurity risks.
State, local, Tribal, and territorial public-health officials get a single federal point of contact for lab biosafety questions, improving coordination and speed of support during incidents.
Researchers, universities, hospitals, biobanks, and distributors will face increased administrative burdens, compliance costs, and operational disruptions to maintain Secretary-prescribed electronic logbooks, identity verification, and custody transfers.
Lab owners, buyers, and institutions risk disclosure of sensitive facility or purchaser information (privacy and proprietary concerns) from recordkeeping requirements and a centralized database.
Listing legal violations and disciplinary actions in a centralized database could cause reputational and commercial harm to facilities and individuals before matters are fully adjudicated.
Based on analysis of 3 sections of legislative text.
Requires electronic transfer logbooks for HHS-listed highly pathogenic agents and mandates federal strategic evaluations and national standards for BSL-3+ labs.
Introduced March 26, 2026 by Catherine Marie Cortez Masto · Last progress March 26, 2026
Requires federal regulation of transfers of specified “highly pathogenic agents” by requiring covered distributors to keep electronic transfer logbooks, verify purchaser identity, and retain records for at least three years. Directs the HHS Secretary to create and maintain a list of covered agents, set logbook formats and disclosure rules, and coordinate with federal agencies on list development. Directs the National Security Advisor to designate a single federal entity to conduct periodic strategic evaluations of U.S. high-containment (BSL-3+) laboratories, develop up-to-date national design and operational standards, create a single federal point of contact for state/local/Tribal/territorial authorities, and study the feasibility of a national database of high-containment labs with ownership, addresses, licensing, and compliance information, reporting results to Congress and the President.